Wealthspire Advisors (New York)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.22M | Sell |
6,137
-3,213
| -34% | -$1.69M | 0.02% | 211 |
|
|
2025
Q1 | $5.93M | Buy |
9,350
+3,731
| +66% | +$2.37M | 0.04% | 151 |
|
|
2024
Q4 | $4M | Sell |
5,619
-2,493
| -31% | -$1.78M | 0.04% | 163 |
|
|
2024
Q3 | $8.53M | Buy |
8,112
+7,643
| +1,630% | +$8.03M | 0.09% | 116 |
|
|
2024
Q2 | $493K | Sell |
469
-15
| -3% | -$15.8K | 0.01% | 435 |
|
|
2024
Q1 | $466K | Sell |
484
-54
| -10% | -$52K | 0.01% | 437 |
|
|
2023
Q4 | $473K | Buy |
538
+80
| +17% | +$70.3K | 0.01% | 427 |
|
|
2023
Q3 | $377K | Buy |
458
+16
| +4% | +$13.2K | 0.01% | 443 |
|
|
2023
Q2 | $318K | Buy |
442
+194
| +78% | +$139K | 0.01% | 452 |
|
|
2023
Q1 | $204K | Sell |
248
-39
| -14% | -$32K | ﹤0.01% | 503 |
|
|
2022
Q4 | $207K | Buy |
+287
| New | +$207K | ﹤0.01% | 534 |
|
|
2021
Q2 | – | Sell |
-718
| Closed | -$340K | – | 596 |
|
|
2021
Q1 | $340K | Sell |
718
-2,767
| -79% | -$1.31M | 0.01% | 516 |
|
|
2020
Q4 | $1.68M | Buy |
3,485
+618
| +22% | +$299K | 0.05% | 151 |
|
|
2020
Q3 | $1.61M | Buy |
2,867
+457
| +19% | +$256K | 0.1% | 99 |
|
|
2020
Q2 | $1.5M | Buy |
2,410
+310
| +15% | +$193K | 0.1% | 82 |
|
|
2020
Q1 | $1.03M | Buy |
2,100
+1,182
| +129% | +$577K | 0.04% | 194 |
|
|
2019
Q4 | $345K | Sell |
918
-27
| -3% | -$10.1K | 0.03% | 132 |
|
|
2019
Q3 | $262K | Buy |
+945
| New | +$262K | 0.02% | 132 |
|
|
2019
Q1 | – | Sell |
-182
| Closed | -$68K | – | 633 |
|
|
2018
Q4 | $68K | Buy |
+182
| New | +$68K | 0.01% | 152 |
|